California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.

Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

This growth comes on the back of a steady market performance from 2017 to 2022, where the injection pen sector achieved a ...